In Vivo Reprogramming in Regenerative Medicine
There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. There...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Humana,
2017.
|
| Edition: | 1st ed. 2017. |
| Series: | Stem Cell Biology and Regenerative Medicine,
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-65720-2 |
Table of Contents:
- Chapter 1. Introduction to in vivo cell Reprogramming Technology
- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells
- Chapter 3. Direct Reprogramming to Beta Cells
- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration
- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency
- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration
- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.